The Anthem Biosciences IPO began on 14 July 2025. It will close on 16 July 2025. The Total IPO Size is 3395 Crores. The company set its IPO price at 570 Rs Per Share.
There are three basic categories in Anthem Biosciences IPO Subscription 1) Qualified Institutional Buyers, 2) Non-Institutional Investors 3) Retail.
Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated
New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing.
The CRDMO platform comprises 5 main modalities (RNAi, ADC, peptides, lipids and oligonucleotides) and 4 manufacturing capabilities (custom synthesis, flow chemistry, fermentation and biotransformation).
Anthem Biosciences IPO Promoters
Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj are Promoters of the company.
Anthem Biosciences IPO Date, Details & Price Band
The Anthem Biosciences IPO Price Band, IPO Dates, Market lot and other details mentioned in the table below.
| IPO Opening Dates | 14-July-2025 |
| IPO Closing Dates | 16-July-2025 |
| Price | 540-570 Rs |
| Offer for Sale | 3,395.00 Crores |
| Total IPO size | 3,395.00 Crores |
| Employee Discount | 50 Rs |
| Face Value | 2 INR Per Share |
| Issue Type | Book Built Issue |
| QIB Allocation | 50% |
| HNI Allocation | 15% |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Anthem Biosciences IPO Market Lot
The Anthem Biosciences IPO minimum market lot is 26 shares with a 14,820 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 26 | 14,820 ₹ |
| Retail Maximum | 13 | 338 | 1,92,660 ₹ |
| S-HNI Minimum | 14 | 364 | 2,07,480 ₹ |
| S-HNI Maximum | 67 | 1,742 | 9,92,940 ₹ |
| B-HNI Minimum | 68 | 1,768 | 10,07,760 ₹ |
Restated Consolidated Financial Information (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-25 | 2,807.58 | 1,930.29 | 451.26 |
| 31-Mar-24 | 2,398.11 | 1,483.07 | 367.31 |
| 31-Mar-23 | 2,014.46 | 1,133.99 | 385.19 |
Anthem Biosciences IPO GMP & Grey Market Premium
Anthem Biosciences IPO GMP Grey market premium has started today. Check the Latest Anthem Biosciences IPO GMP, Kostak Rates, and Subject to Sauda Price here.
Anthem Biosciences IPO Prospectus
Anthem Biosciences IPO Prospectus is Available on the NSE/BSE and Sebi Website as well as on our Portal. Please click here to download the Anthem Biosciences IPO Prospectus.
| DRHP | Download |
| RHP | Download |
| Anchor Investor List | Download |
Anthem Biosciences IPO Allotment Date & Details
| Allotment Date | 17-July-2025 |
| Initiation of refunds | 18-July-2025 |
| Transfer of shares to Demat accounts | 18-July-2025 |
| Listing Date | 21-July-2025 |
| Check Allotment Status | Click here |
Registrar of Anthem Biosciences
KFin Technologies Limited
Selenium, Tower B, Plot No- 31 and 32, Financial
District, Nanakramguda, Serilingampally, Hyderabad,
Rangareddy 500 032, Telangana, India
Telephone: +91 40 6716 2222
E-mail: [email protected]
Investor grievance E-mail:
[email protected]
Website: www.kfintech.com
Contact person: M. Murali Krishna
SEBI registration number: INR000000221
Anthem Biosciences Contact Details
Anthem Biosciences Ltd.
No. 49, F1 & F2, Canara Bank Road
Bommasandra Industrial Area, Phase 1,
Bommasandra,
Bengaluru, Karnataka, 560099
Phone: +91 080 6672 400
Email: [email protected]
Website: https://www.anthembio.com/
Anthem Biosciences IPO Lead Managers
Citigroup Global Markets India Private Limited
JM Financial Limited
J.P. Morgan India Private Limited
Nomura Financial Advisory and Securities (India) Private Limited
